Announced Tue, 27 Oct, 2026 · 21:30 IST
Syngene Q2 profit rebounds and wins first Bayview manufacturing deal
SYNGENE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction
Awaiting price reaction for this filing.
AI summary
Q2 FY27 revenue was Rs 833 crore, up 13% from Q1 but down 9% year on year. EBITDA margin improved to 18% from 12% in Q1. Adjusted profit, before employee termination charges, rose to Rs 38 crore from Rs 1 crore. First-half revenue fell 12% to Rs 1,569 crore and adjusted profit was Rs 39 crore versus Rs 154 crore. Syngene signed its first Bayview manufacturing deal and added biologics contracts; cost savings are expected over coming quarters.
Likely market impact
Q2 recovery and new contracts support growth, but first-half results are below last year; further margin gains depend on cost savings.